Atara Biotherapeutics

Performance

About Atara Biotherapeutics

Atara Biotherapeutics is a biopharmaceutical company focused on developing off-the-shelf, allogeneic T-cell immunotherapies. The company’s pipeline targets cancer, autoimmune diseases, and viral diseases with an emphasis on rapid, scalable manufacturing and a versatile CAR T-like platform. Headquartered in the United States, Atara emphasizes first-in-class therapies that can be delivered rapidly from inventory to patients in need.